Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) PDF $40.00
$40.00
× Placeholder Osmotic-Release Oral System Methylphenidate Augmentation of Antidepressant Monotherapy in Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder Underrecognition of Clinically Significant Side Effects in Depressed Outpatients PDF $40.00
$40.00
× Placeholder QT Interval Prolongation in Users of Selective Serotonin Reuptake Inhibitors in an Elderly Surgical Population: A Cross-Sectional Study PDF $40.00
$40.00
× Placeholder New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $240.00
Total $240.00
Proceed to checkout

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe